TELA Bio (TELA) Cash from Investing Activities (2018 - 2026)
TELA Bio (TELA) posted Cash from Investing Activities of $239000.0 for Q2 2026, up 25.79% on a QoQ basis from $190000.0 in Q1 2026, and up 17.16% year-over-year from $204000.0 in Q2 2025.
Powered by 
Analysis
TELA Bio (TELA) Cash from Investing Activities (2018 - 2026) Analysis & Trends
TELA Bio has reported Cash from Investing Activities for 9 years, with the latest figure at $239000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 17.16% year-over-year to $239000.0 in Q2 2026; TTM through Jun 2026 was $933000.0, a 3010.0% increase from a year earlier, with the FY2025 full-year figure at $846000.0, down 80.99% from the prior year.
- Cash from Investing Activities was $239000.0 for Q2 2026 at TELA Bio, up from $190000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $4.7 million in Q1 2024, with the low at -$1.0 million in Q4 2022.
- Average Cash from Investing Activities over 5 years is $180833.3, with a median of -$118500.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities plunged 1427.27% in 2022, then jumped 4183.48% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$1.0 million in 2022, then soared by 81.55% to -$193000.0 in 2023, then advanced by 1.55% to -$190000.0 in 2024, then jumped by 201.05% to $192000.0 in 2025, then increased by 24.48% to $239000.0 in 2026.
- The last three Cash from Investing Activities figures came in at $239000.0 (Q2 2026), $190000.0 (Q1 2026), and $192000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | -108.50 Mn |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | 239,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | -190,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | -193,000.00 |
| Sep 30, 2023 | -134,000.00 |
| Jun 30, 2023 | -157,000.00 |
| Mar 31, 2023 | -115,000.00 |
| Dec 31, 2022 | -1.05 Mn |
| Sep 30, 2022 | -290,000.00 |
| Jun 30, 2022 | -200,000.00 |
| Mar 31, 2022 | -336,000.00 |
| Dec 31, 2021 | -289,000.00 |
| Sep 30, 2021 | -291,000.00 |